Related Experiment Video
Updated: Jul 22, 2026

Orthotopic Small Bowel Transplantation in Rats
Published on: November 6, 2012
Keratinocyte growth factor enhances early gut adaptation in a rat model of short bowel syndrome
W F Johnson1, C R DiPalma, T R Ziegler
1Department of Pathology, Amgen, Inc, Thousand Oaks, CA, USA.
Objective:
To evaluate the effects of keratinocyte growth factor (KGF) on intestinal adaptation after resection of 85% of the small intestine and consider its potential application in short bowel syndrome (SBS).
Study Design:
Experimental study using a known model of SBS.
Animal Population:
Thirty male Sprague Dawley rats.
Methods:
Four groups of animals were designated. Two groups underwent 85% resection of the small intestine, while the other two groups were sham-operated, undergoing transection and reanastomosis. Resected and sham-operated groups then received either 3 mg/kg KGF or vehicle subcutaneously daily for 3 days. Gut adaptation was evaluated by measurements of mucosal cellularity and biochemical activity in duodenal, jejunal, and ileal segments.
Results:
Significant small intestinal growth after bowel resection alone was confirmed in resected versus sham-operated rats. KGF further augmented this growth in the resected animals. Mucosal wet weight of the small intestine increased with resection and was further increased (by 20% or more) with KGF administration. Mucosal thickness, villus length, and crypt depth exhibited similar patterns of response. The KGF-induced increase in mucosal morphology was accompanied by increased mucosal DNA and protein content, followed by a trend toward increased mucosal enzyme activity. Histology demonstrated an increase in goblet cells in KGF-treated animals. In situ hybridization analysis demonstrated that KGF markedly increased mucosal expression of intestinal trefoil protein (ITF) mRNA.
Conclusions:
KGF enhances gut growth, differentiation, and gene regulation during adaptation in rat small intestine after massive resection.
Clinical Relevance:
KGF may be beneficial in the management of veterinary and human patients undergoing massive intestinal resection.

